No profile data available.
Bimi Holdings Inc. (BIMI) is an essential consumer products company in the medication retail outlets industry, based in New York, United States, with about 296 full-time employees.
It reported revenue of $11.83 million for fiscal year 2022, down 44.5% from fiscal year 2021, and net income of -$22.39 million. In Q3 2023 (the quarter ended September 30, 2023) revenue was $2.52 million, down 48.8% from a year before. Its largest business segment, Wholesale pharmaceuticals, brought in 58% of segment revenue in fiscal year 2022. Its market capitalization was $6,980 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2022; market data as of October 8, 2026.
, together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail.
Bimi reported $11.83 million in revenue for fiscal year 2022, down 44.5% from $21.32 million in fiscal year 2021. In Q3 2023 revenue was $2.52 million.
Wholesale pharmaceuticals, with $6.83 million or 58% of segment revenue in fiscal year 2022. Next: Wholesale medical devices (35%) and Retail Pharmacy (7%).
$6,980 as of October 8, 2026.
Listed companies of a similar size in the same industry (medication retail outlets) include PeakBirch Commerce Inc. (PKBFF), Islet Holdings, Inc. (ISHI), ScripsAmerica, Inc. (SCRCQ), MedGen, Inc. (MDIN).